Translational Development Acquisition Corp. (TDACU) Notes Payables (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Notes Payables came in at $500000.0 in Q1 2026, up 150.0% on a QoQ basis from $200000.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Notes Payables (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 3 years of Notes Payables data on file, last reported at $500000.0 in Q1 2026.
- Quarterly Notes Payables changed N/A year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $500000.0 (changed N/A YoY) and the FY2025 annual result came in at $200000.0, changed N/A from the prior year.
- Notes Payables climbed to $500000.0 in Q1 2026, from $200000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $500000.0 in Q1 2026 to a low of $100000.0 in Q3 2025.
- A 3-year average of $286875.0 and a median of $273750.0 in 2023 frame the typical range for Notes Payables.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Dec 31, 2023 | 347,500.00 |